Immunotherapy: How the Immune System Conquers Cancer

Added:

What is it?
The origin
Immune basics
Checkpoint drugs
Stimulate
Personalized
Complexity
Looking ahead

What is it?

0:08
Playing Section
  • 1

    Introduces immunotherapy as a treatment that uses our immune system to fight cancer.

  • 2

    Explains it has already been used in vaccines for various diseases.

  • 3

    Acknowledges cancer is complex and harder to treat than viruses.

Basic anatomy and physiology of the human immune system, specifically the roles of T-cells, B-cells, and antigen-presenting cells (APCs).
Fundamentals of cancer biology, including how genetic mutations lead to uncontrolled cell division and tumor formation.
The concept of antigen recognition and how the immune system distinguishes between 'self' and 'non-self' or abnormal cells.
The physiological purpose of immune checkpoint pathways (such as PD-1 and CTLA-4) in preventing autoimmunity in healthy tissues.
Clinical challenges of immunotherapy, including mechanisms of tumor resistance and the management of immune-related adverse events (irAEs) like cytokine release syndrome.
The design and genetic engineering process behind CAR-T cell manufacturing, including viral vectors and gene editing technologies.
Advanced clinical applications, such as combination therapies pairing immunotherapy with chemotherapy, radiation, or targeted molecular therapies.
Personalized medicine in oncology, specifically the use of biomarkers (e.g., tumor mutational burden and PD-L1 expression) to predict patient response to immunotherapies.
104.2K views1.6Klikes15:34@TEDxOriginal Release: 2016-12-21

Immunotherapy is a revolutionary cancer treatment approach that leverages the body's immune system to recognize and destroy cancer cells, representing a paradigm shift from traditional treatments like surgery, chemotherapy, and radiation. The immune system identifies cancer cells through molecular markers on cell surfaces, but tumors often develop protective checkpoints that suppress immune responses. Modern immunotherapies, including checkpoint inhibitors (which block these off-switches), CAR T-cell therapy (which engineers patients' immune cells to target cancer), and personalized vaccines (which teach the immune system to recognize unique tumor mutations), have shown remarkable success in treating previously untreatable cancers. These advances demonstrate that cancer treatment is moving toward personalized, precision medicine tailored to each patient's specific tumor characteristics.